As steadily increasing numbers of mRNA vaccines and therapeutics advance through clinical trials and commercialization, the biopharmaceutical industry is pressed to find ways to make their production ...
This is a preview. Log in through your library . Abstract OPA1, a dynamin-related guanosine triphosphatase mutated in dominant optic atrophy, is required for the fusion of mitochondria. Proteolytic ...
A new synthesis method offers hope for creation of advance mRNA vaccines to fight viruses and even cancers. Researchers at Nagoya University in Japan have developed a new chemical-only process that ...
New research found that mRNA vaccines for COVID-19 could enhance cancer treatments and help patients live longer.
Hosted on MSN
Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines
A research team led by Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA cancer vaccine platform. The study introduces an immune cell homing ...
Much of the research into α-synuclein, the major component of Lewy bodies in Parkinson’s and other neurodegenerative diseases, focuses on its role in synaptic vesicles and membranes. But could other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback